Darren A. Thompson, Ph.D. - Publications

University of California, Santa Cruz, Santa Cruz, CA, United States 

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Cistrone PA, Bird MJ, Flood DT, Silvestri AP, Hintzen JCJ, Thompson DA, Dawson PE. Native Chemical Ligation of Peptides and Proteins. Current Protocols in Chemical Biology. e61. PMID 30645048 DOI: 10.1002/Cpch.61  0.591
2017 Breger JC, Muttenthaler M, Delehanty JB, Thompson DA, Oh E, Susumu K, Deschamps JR, Anderson GP, Field LD, Walper SA, Dawson PE, Medintz IL. Nanoparticle cellular uptake by dendritic wedge peptides: achieving single peptide facilitated delivery. Nanoscale. PMID 28703833 DOI: 10.1039/C7Nr03362A  0.539
2016 Thompson DA, Ng R, Dawson PE. Arginine selective reagents for ligation to peptides and proteins. Journal of Peptide Science : An Official Publication of the European Peptide Society. PMID 27005702 DOI: 10.1002/Psc.2867  0.587
2014 Thompson DA, Evans EG, Kasza T, Millhauser GL, Dawson PE. Adapter reagents for protein site specific dye labeling. Biopolymers. 102: 273-9. PMID 24599728 DOI: 10.1002/Bip.22481  0.66
2013 Boeneman K, Delehanty JB, Blanco-Canosa JB, Susumu K, Stewart MH, Oh E, Huston AL, Dawson G, Ingale S, Walters R, Domowicz M, Deschamps JR, Algar WR, Dimaggio S, Manono J, ... ... Thompson D, et al. Selecting improved peptidyl motifs for cytosolic delivery of disparate protein and nanoparticle materials. Acs Nano. 7: 3778-96. PMID 23710591 DOI: 10.1021/Nn400702R  0.575
2013 Shelby SJ, Colwill K, Dhe-Paganon S, Pawson T, Thompson DA. MERTK interactions with SH2-domain proteins in the retinal pigment epithelium. Plos One. 8: e53964. PMID 23390493 DOI: 10.1371/journal.pone.0053964  0.305
2012 Ersoy BA, Pardo L, Zhang S, Thompson DA, Millhauser G, Govaerts C, Vaisse C. Mechanism of N-terminal modulation of activity at the melanocortin-4 receptor GPCR. Nature Chemical Biology. 8: 725-30. PMID 22729149 DOI: 10.1038/Nchembio.1008  0.66
2010 Zhang C, Song Y, Thompson DA, Madonna MA, Millhauser GL, Toro S, Varga Z, Westerfield M, Gamse J, Chen W, Cone RD. Pineal-specific agouti protein regulates teleost background adaptation. Proceedings of the National Academy of Sciences of the United States of America. 107: 20164-71. PMID 20980662 DOI: 10.1073/Pnas.1014941107  0.56
2010 Sampathkumar P, Ozyurt SA, Miller SA, Bain KT, Rutter ME, Gheyi T, Abrams B, Wang Y, Atwell S, Luz JG, Thompson DA, Wasserman SR, Emtage JS, Park EC, Rongo C, et al. Structures of PHR domains from Mus musculus Phr1 (Mycbp2) explain the loss-of-function mutation (Gly1092-->Glu) of the C. elegans ortholog RPM-1. Journal of Molecular Biology. 397: 883-92. PMID 20156452 DOI: 10.1016/J.Jmb.2010.02.017  0.314
2009 Sánchez E, Rubio VC, Thompson D, Metz J, Flik G, Millhauser GL, Cerdá-Reverter JM. Phosphodiesterase inhibitor-dependent inverse agonism of agouti-related protein on melanocortin 4 receptor in sea bass (Dicentrarchus labrax) American Journal of Physiology - Regulatory Integrative and Comparative Physiology. 296: R1293-R1306. PMID 19225141 DOI: 10.1152/Ajpregu.90948.2008  0.659
2008 Kaelin CB, Candille SI, Yu B, Jackson P, Thompson DA, Nix MA, Binkley J, Millhauser GL, Barsh GS. New ligands for melanocortin receptors. International Journal of Obesity (2005). 32: S19-27. PMID 19136986 DOI: 10.1038/Ijo.2008.234  0.753
2007 Candille SI, Kaelin CB, Cattanach BM, Yu B, Thompson DA, Nix MA, Kerns JA, Schmutz SM, Millhauser GL, Barsh GS. A -defensin mutation causes black coat color in domestic dogs. Science (New York, N.Y.). 318: 1418-23. PMID 17947548 DOI: 10.1126/Science.1147880  0.674
2006 Lee YS, Challis BG, Thompson DA, Yeo GS, Keogh JM, Madonna ME, Wraight V, Sims M, Vatin V, Meyre D, Shield J, Burren C, Ibrahim Z, Cheetham T, Swift P, et al. A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metabolism. 3: 135-40. PMID 16459314 DOI: 10.1016/J.Cmet.2006.01.006  0.716
2005 Jackson PJ, Yu B, Hunrichs B, Thompson DA, Chai B, Gantz I, Millhauser GL. Chimeras of the agouti-related protein: Insights into agonist and antagonist selectivity of melanocortin receptors Peptides. 26: 1978-1987. PMID 16009463 DOI: 10.1016/J.Peptides.2004.12.036  0.783
2005 McNulty JC, Jackson PJ, Thompson DA, Chai B, Gantz I, Barsh GS, Dawson PE, Millhauser GL. Structures of the agouti signaling protein. Journal of Molecular Biology. 346: 1059-70. PMID 15701517 DOI: 10.1016/J.Jmb.2004.12.030  0.773
2004 Hartley O, Gaertner H, Wilken J, Thompson D, Fish R, Ramos A, Pastore C, Dufour B, Cerini F, Melotti A, Heveker N, Picard L, Alizon M, Mosier D, Kent S, et al. Medicinal chemistry applied to a synthetic protein: Development of highly potent HIV entry inhibitors Proceedings of the National Academy of Sciences of the United States of America. 101: 16460-16465. PMID 15545608 DOI: 10.1073/Pnas.0404802101  0.668
2003 Chai BX, Neubig RR, Millhauser GL, Thompson DA, Jackson PJ, Barsh GS, Dickinson CJ, Li JY, Lai YM, Gantz I. Inverse agonist activity of agouti and agouti-related protein. Peptides. 24: 603-9. PMID 12860205 DOI: 10.1016/S0196-9781(03)00104-9  0.744
2003 Millhauser GL, McNulty JC, Jackson PJ, Thompson DA, Barsh GS, Gantz I. Loops and links: structural insights into the remarkable function of the agouti-related protein. Annals of the New York Academy of Sciences. 994: 27-35. PMID 12851295 DOI: 10.1111/J.1749-6632.2003.Tb03159.X  0.801
2003 Thompson DA, Chai BX, Rood HLE, Siani MA, Douglas NR, Gantz I, Millhauser GL. Peptoid mimics of agouti related protein Bioorganic and Medicinal Chemistry Letters. 13: 1409-1413. PMID 12668001 DOI: 10.1016/S0960-894X(03)00164-1  0.643
2002 McNulty JC, Thompson DA, Carrasco MR, Millhauser GL. Dap-SL: A new site-directed nitroxide spin labeling approach for determining structure and motions in synthesized peptides and proteins Febs Letters. 529: 243-248. PMID 12372608 DOI: 10.1016/S0014-5793(02)03352-5  0.742
2002 Jackson PJ, McNulty JC, Yang YK, Thompson DA, Chai B, Gantz I, Barsh GS, Millhauser GL. Design, pharmacology, and NMR structure of a minimized cystine knot with agouti-related protein activity. Biochemistry. 41: 7565-72. PMID 12056887 DOI: 10.1021/Bi012000X  0.797
2001 McNulty JC, Thompson DA, Bolin KA, Wilken J, Barsh GS, Millhauser GL. High-resolution NMR structure of the chemically-synthesized melanocortin receptor binding domain AGRP(87-132) of the agouti-related protein. Biochemistry. 40: 15520-7. PMID 11747427 DOI: 10.1021/Bi0117192  0.799
2001 Shao W, Fernandez E, Sachpatzidis A, Wilken J, Thompson DA, Schweitzer BI, Lolis E. CCR2 and CCR5 receptor-binding properties of herpesvirus-8 vMIP-II based on sequence analysis and its solution structure. European Journal of Biochemistry / Febs. 268: 2948-59. PMID 11358512 DOI: 10.1046/J.1432-1327.2001.02184.X  0.497
2000 Fernandez EJ, Wilken J, Thompson DA, Peiper SC, Lolis E. Comparison of the structure of vMIP-II with eotaxin-1, RANTES, and MCP-3 suggests a unique mechanism for CCR3 activation Biochemistry. 39: 12837-12844. PMID 11041848 DOI: 10.1021/Bi001166F  0.375
2000 Pelletier AJ, van der Laan LJ, Hildbrand P, Siani MA, Thompson DA, Dawson PE, Torbett BE, Salomon DR. Presentation of chemokine SDF-1 alpha by fibronectin mediates directed migration of T cells. Blood. 96: 2682-90. PMID 11023498  0.486
2000 Pelletier AJ, Laan LJWvd, Hildbrand P, Siani MA, Thompson DA, Dawson PE, Torbett BE, Salomon DR. Presentation of chemokine SDF-1α by fibronectin mediates directed migration of T cells Blood. 96: 2682-2690. DOI: 10.1182/Blood.V96.8.2682.H8002682_2682_2690  0.522
1999 Panzer U, Schneider A, Wilken J, Thompson DA, Kent SB, Stahl RA. The chemokine receptor antagonist AOP-RANTES reduces monocyte infiltration in experimental glomerulonephritis. Kidney International. 56: 2107-15. PMID 10594786 DOI: 10.1046/J.1523-1755.1999.00767.X  0.67
1999 Rusconi S, La Seta-Catamancio S, Kurtagic S, Galazzi M, Arienti D, Trabattoni D, Wilken J, Thompson DA, Offord RE, Galli M, Clerici M. Aminooxypentane-RANTES, an inhibitor of R5 human immunodeficiency virus type 1, increases the interferon γ to interleukin 10 ratio without impairing cellular proliferation Aids Research and Human Retroviruses. 15: 861-867. PMID 10408722 DOI: 10.1089/088922299310566  0.308
1999 Bolin KA, Anderson DJ, Trulson JA, Thompson DA, Wilken J, Kent SB, Gantz I, Millhauser GL. NMR structure of a minimized human agouti related protein prepared by total chemical synthesis. Febs Letters. 451: 125-31. PMID 10371151 DOI: 10.1016/S0014-5793(99)00553-0  0.759
1999 Mosier DE, Picchio GR, Gulizia RJ, Sabbe R, Poignard P, Picard L, Offord RE, Thompson DA, Wilken J. Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4- using variants Journal of Virology. 73: 3544-3550. PMID 10196243 DOI: 10.1128/Jvi.73.5.3544-3550.1999  0.335
1999 Yang YK, Thompson DA, Dickinson CJ, Wilken J, Barsh GS, Kent SB, Gantz I. Characterization of Agouti-related protein binding to melanocortin receptors. Molecular Endocrinology (Baltimore, Md.). 13: 148-55. PMID 9892020 DOI: 10.1210/Mend.13.1.0223  0.726
1999 Wilken J, Hoover D, Thompson DA, Barlow PN, McSparron H, Picard L, Wlodawer A, Lubkowski J, Kent SB. Total chemical synthesis and high-resolution crystal structure of the potent anti-HIV protein AOP-RANTES. Chemistry & Biology. 6: 43-51. PMID 9889151 DOI: 10.1016/S1074-5521(99)80019-2  0.702
1998 Shao W, Fernandez E, Wilken J, Thompson DA, Siani MA, West J, Lolis E, Schweitzer BI. Accessibility of selenomethionine proteins by total chemical synthesis: Structural studies of human herpesvirus-8 MIP-II Febs Letters. 441: 77-82. PMID 9877169 DOI: 10.1016/S0014-5793(98)01520-8  0.38
1998 Harrison JK, Jiang Y, Chen S, Xia Y, Maciejewski D, McNamara RK, Streit WJ, Salafranca MN, Adhikari S, Thompson DA, Botti P, Bacon KB, Feng L. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proceedings of the National Academy of Sciences of the United States of America. 95: 10896-901. PMID 9724801 DOI: 10.1073/Pnas.95.18.10896  0.323
1998 Chen S, Bacon KB, Li L, Garcia GE, Xia Y, Lo D, Thompson DA, Siani MA, Yamamoto T, Harrison JK, Feng L. In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. The Journal of Experimental Medicine. 188: 193-8. PMID 9653095 DOI: 10.1084/Jem.188.1.193  0.411
1998 Dealwis C, Fernandez EJ, Thompson DA, Simon RJ, Siani MA, Lolis E. Crystal structure of chemically synthesized [N33A] stromal cell-derived factor 1alpha, a potent ligand for the HIV-1 "fusin" coreceptor. Proceedings of the National Academy of Sciences of the United States of America. 95: 6941-6. PMID 9618518 DOI: 10.1073/Pnas.95.12.6941  0.381
1998 Campbell JJ, Bowman EP, Murphy K, Youngman KR, Siani MA, Thompson DA, Wu L, Zlotnik A, Butcher EC. 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3β receptor CCR7 Journal of Cell Biology. 141: 1053-1059. PMID 9585422 DOI: 10.1083/Jcb.141.4.1053  0.387
1998 Trkola A, Paxton WA, Monard SP, Hoxie JA, Siani MA, Thompson DA, Wu L, Mackay CR, Horuk R, Moore JP. Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines Journal of Virology. 72: 396-404. PMID 9420238 DOI: 10.1128/Jvi.72.1.396-404.1998  0.345
1997 Davis CB, Dikic I, Unutmaz D, Hill CM, Arthos J, Siani MA, Thompson DA, Schlessinger J, Littman DR. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. The Journal of Experimental Medicine. 186: 1793-8. PMID 9362541 DOI: 10.1084/Jem.186.10.1793  0.355
Show low-probability matches.